Year |
Citation |
Score |
2018 |
Smither SJ, Eastaugh L, Filone CM, Freeburger D, Herzog A, Lever MS, Miller DM, Mitzel D, Noah JW, Reddick-Elick MS, Reese A, Schuit M, Wlazlowski CB, Hevey M, Wahl-Jensen V. Two-Center Evaluation of Disinfectant Efficacy against Ebola Virus in Clinical and Laboratory Matrices. Emerging Infectious Diseases. 24. PMID 29261093 DOI: 10.3201/Eid2401.170504 |
0.382 |
|
2016 |
Schuit M, Miller DM, Reddick-Elick MS, Wlazlowski CB, Filone CM, Herzog A, Colf LA, Wahl-Jensen V, Hevey M, Noah JW. Differences in the Comparative Stability of Ebola Virus Makona-C05 and Yambuku-Mayinga in Blood. Plos One. 11: e0148476. PMID 26849135 DOI: 10.1371/Journal.Pone.0148476 |
0.323 |
|
2015 |
Evans CW, Atkins C, Pathak A, Gilbert BE, Noah JW. Benzimidazole analogs inhibit respiratory syncytial virus G protein function. Antiviral Research. 121: 31-38. PMID 26116756 DOI: 10.1016/J.Antiviral.2015.06.016 |
0.679 |
|
2015 |
Londino JD, Lazrak A, Noah JW, Aggarwal S, Bali V, Woodworth BA, Bebok Z, Matalon S. Influenza virus M2 targets cystic fibrosis transmembrane conductance regulator for lysosomal degradation during viral infection. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 29: 2712-25. PMID 25795456 DOI: 10.1096/Fj.14-268755 |
0.493 |
|
2015 |
Rasmussen L, Tigabu B, White EL, Bostwick R, Tower N, Bukreyev A, Rockx B, LeDuc JW, Noah JW. Adapting high-throughput screening methods and assays for biocontainment laboratories. Assay and Drug Development Technologies. 13: 44-54. PMID 25710545 DOI: 10.1089/Adt.2014.617 |
0.321 |
|
2015 |
Zarogiannis S, Londino J, Chen L, Li Q, Lancaster J, Noah J, Noah D, Matalon S. LSC Abstract – Epithelial sodium channel (ENaC) currents and superoxide and hydroxyl formation in influenza H1N1 infected rat primary alveolar type II cells European Respiratory Journal. 46. DOI: 10.1183/13993003.Congress-2015.Pa3021 |
0.462 |
|
2014 |
Matharu DS, Flaherty DP, Simpson DS, Schroeder CE, Chung D, Yan D, Noah JW, Jonsson CB, White EL, Aubé J, Plemper RK, Severson WE, Golden JE. Optimization of potent and selective quinazolinediones: inhibitors of respiratory syncytial virus that block RNA-dependent RNA-polymerase complex activity. Journal of Medicinal Chemistry. 57: 10314-28. PMID 25399509 DOI: 10.1021/Jm500902X |
0.417 |
|
2014 |
Schroeder CE, Yao T, Sotsky J, Smith RA, Roy S, Chu YK, Guo H, Tower NA, Noah JW, McKellip S, Sosa M, Rasmussen L, Smith LH, White EL, Aubé J, et al. Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus. Journal of Medicinal Chemistry. 57: 8608-21. PMID 25244572 DOI: 10.1021/Jm501203V |
0.505 |
|
2014 |
Goller CC, Arshad M, Noah JW, Ananthan S, Evans CW, Nebane NM, Rasmussen L, Sosa M, Tower NA, White EL, Neuenswander B, Porubsky P, Maki BE, Rogers SA, Schoenen F, et al. Lifting the mask: identification of new small molecule inhibitors of uropathogenic Escherichia coli group 2 capsule biogenesis. Plos One. 9: e96054. PMID 24983234 DOI: 10.1371/Journal.Pone.0096054 |
0.436 |
|
2014 |
Chung DH, Jonsson CB, Tower NA, Chu YK, Sahin E, Golden JE, Noah JW, Schroeder CE, Sotsky JB, Sosa MI, Cramer DE, McKellip SN, Rasmussen L, White EL, Schmaljohn CS, et al. Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2. Plos Pathogens. 10: e1004213. PMID 24967809 DOI: 10.1371/Journal.Ppat.1004213 |
0.541 |
|
2014 |
Tigabu B, Rasmussen L, White EL, Tower N, Saeed M, Bukreyev A, Rockx B, LeDuc JW, Noah JW. A BSL-4 high-throughput screen identifies sulfonamide inhibitors of Nipah virus. Assay and Drug Development Technologies. 12: 155-61. PMID 24735442 DOI: 10.1089/Adt.2013.567 |
0.548 |
|
2014 |
Atkins C, Evans CW, Nordin B, Patricelli MP, Reynolds R, Wennerberg K, Noah JW. Global Human-Kinase Screening Identifies Therapeutic Host Targets against Influenza. Journal of Biomolecular Screening. 19: 936-946. PMID 24464431 DOI: 10.1177/1087057113518068 |
0.683 |
|
2013 |
Noah DL, Noah JW. Adapting global influenza management strategies to address emerging viruses. American Journal of Physiology. Lung Cellular and Molecular Physiology. 305: L108-17. PMID 23709619 DOI: 10.1152/Ajplung.00105.2013 |
0.444 |
|
2013 |
Londino JD, Lazrak A, Jurkuvenaite A, Collawn JF, Noah JW, Matalon S. Influenza matrix protein 2 alters CFTR expression and function through its ion channel activity. American Journal of Physiology. Lung Cellular and Molecular Physiology. 304: L582-92. PMID 23457187 DOI: 10.1152/Ajplung.00314.2012 |
0.309 |
|
2012 |
Moore BP, Chung DH, Matharu DS, Golden JE, Maddox C, Rasmussen L, Noah JW, Sosa MI, Ananthan S, Tower NA, White EL, Jia F, Prisinzano TE, Aubé J, Jonsson CB, et al. (S)-N-(2,5-Dimethylphenyl)-1-(quinoline-8-ylsulfonyl)pyrrolidine-2-carboxamide as a small molecule inhibitor probe for the study of respiratory syncytial virus infection. Journal of Medicinal Chemistry. 55: 8582-7. PMID 23043370 DOI: 10.1021/Jm300612Z |
0.5 |
|
2012 |
Atkins C, Evans CW, White EL, Noah JW. Screening methods for influenza antiviral drug discovery. Expert Opinion On Drug Discovery. 7: 429-38. PMID 22435452 DOI: 10.1517/17460441.2012.674510 |
0.68 |
|
2012 |
Zarogiannis SG, Noah JW, Jurkuvenaite A, Steele C, Matalon S, Noah DL. Comparison of ribavirin and oseltamivir in reducing mortality and lung injury in mice infected with mouse adapted A/California/04/2009 (H1N1). Life Sciences. 90: 440-5. PMID 22269828 DOI: 10.1016/J.Lfs.2011.12.014 |
0.348 |
|
2012 |
Seguin SP, Evans CW, Nebane-Akah M, McKellip S, Ananthan S, Tower NA, Sosa M, Rasmussen L, White EL, Maki BE, Matharu DS, Golden JE, Aubé J, Brodsky JL, Noah JW. High-throughput screening identifies a bisphenol inhibitor of SV40 large T antigen ATPase activity. Journal of Biomolecular Screening. 17: 194-203. PMID 21948801 DOI: 10.1177/1087057111421630 |
0.434 |
|
2011 |
Schormann N, Sommers CI, Prichard MN, Keith KA, Noah JW, Nuth M, Ricciardi RP, Chattopadhyay D. Identification of protein-protein interaction inhibitors targeting vaccinia virus processivity factor for development of antiviral agents. Antimicrobial Agents and Chemotherapy. 55: 5054-62. PMID 21844323 DOI: 10.1128/Aac.00278-11 |
0.357 |
|
2011 |
Li W, Noah JW, Noah DL. Alanine substitutions within a linker region of the influenza A virus non-structural protein 1 alter its subcellular localization and attenuate virus replication. The Journal of General Virology. 92: 1832-42. PMID 21508188 DOI: 10.1099/Vir.0.031336-0 |
0.467 |
|
2011 |
Maddry JA, Chen X, Jonsson CB, Ananthan S, Hobrath J, Smee DF, Noah JW, Noah D, Xu X, Jia F, Maddox C, Sosa MI, White EL, Severson WE. Discovery of novel benzoquinazolinones and thiazoloimidazoles, inhibitors of influenza H5N1 and H1N1 viruses, from a cell-based high-throughput screen. Journal of Biomolecular Screening. 16: 73-81. PMID 21059874 DOI: 10.1177/1087057110384613 |
0.546 |
|
2010 |
Falk SP, Noah JW, Weisblum B. Screen for inducers of autolysis in Bacillus subtilis. Antimicrobial Agents and Chemotherapy. 54: 3723-9. PMID 20606070 DOI: 10.1128/Aac.01597-09 |
0.348 |
|
2010 |
Passer BJ, Cheema T, Zhou B, Wakimoto H, Zaupa C, Razmjoo M, Sarte J, Wu S, Wu CL, Noah JW, Li Q, Buolamwini JK, Yen Y, Rabkin SD, Martuza RL. Identification of the ENT1 antagonists dipyridamole and dilazep as amplifiers of oncolytic herpes simplex virus-1 replication. Cancer Research. 70: 3890-5. PMID 20424118 DOI: 10.1158/0008-5472.Can-10-0155 |
0.496 |
|
2010 |
Severson W, Chen X, Jonsson C, Maddox C, Maddry J, Noah J, Ontiveros S, Parker W, Smee D. Optimization of Novel Broad Spectrum Anti-influenza Therapeutics Antiviral Research. 86: A46. DOI: 10.1016/J.Antiviral.2010.02.410 |
0.352 |
|
2009 |
Lazrak A, Iles KE, Liu G, Noah DL, Noah JW, Matalon S. Influenza virus M2 protein inhibits epithelial sodium channels by increasing reactive oxygen species. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 3829-42. PMID 19596899 DOI: 10.1096/Fj.09-135590 |
0.366 |
|
2009 |
Noah JW, Noah DL, Matalon S. Influenza exerts continued pressure in an era of modern medicine. American Journal of Respiratory Cell and Molecular Biology. 41: 3-7. PMID 19423770 DOI: 10.1165/Rcmb.2009-0158Ed |
0.395 |
|
2009 |
Severson W, Chen X, Maddry J, Chu Y, Jonsson C, McBrayer A, Tapp R, Smee D, Maddox C, Ananthan S, Noah J, Black L, Moore B, Sosa M, White L, et al. Discovery of New Inhibitors of the Influenza H5N1 Virus Antiviral Research. 82: A36-A37. DOI: 10.1016/J.Antiviral.2009.02.073 |
0.485 |
|
2008 |
Severson WE, McDowell M, Ananthan S, Chung DH, Rasmussen L, Sosa MI, White EL, Noah J, Jonsson CB. High-throughput screening of a 100,000-compound library for inhibitors of influenza A virus (H3N2). Journal of Biomolecular Screening. 13: 879-87. PMID 18812571 DOI: 10.1177/1087057108323123 |
0.522 |
|
2007 |
Noah JW, Severson W, Noah DL, Rasmussen L, White EL, Jonsson CB. A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals. Antiviral Research. 73: 50-9. PMID 16904762 DOI: 10.1016/J.Antiviral.2006.07.006 |
0.552 |
|
2007 |
Severson W, McDowell M, Rasumussen L, Sosa M, Ananthan S, Noah J, White L, Jonsson C. High Throughput Screening of a 100,000 Compound Library for Inhibitors of Influenza A Virus (H3N2) Antiviral Research. 74. DOI: 10.1016/J.Antiviral.2007.01.092 |
0.547 |
|
Show low-probability matches. |